- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x JDG: 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine(Non-covalent)
- 8 x ZN: ZINC ION(Non-covalent)
ZN.2: 7 residues within 4Å:- Chain A: C.57, C.63, C.100, C.106, C.110
- Ligands: ZN.3, ZN.4
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.63, A:C.100, A:C.106, A:C.110
ZN.3: 6 residues within 4Å:- Chain A: C.57, C.70, C.100, C.104
- Ligands: ZN.2, ZN.4
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.57, A:C.70, A:C.100, A:C.104
ZN.4: 6 residues within 4Å:- Chain A: C.57, C.59, C.63, C.68
- Ligands: ZN.2, ZN.3
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.57, A:C.59, A:C.63, A:C.68
ZN.5: 4 residues within 4Å:- Chain A: C.198, C.251, C.253, C.258
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.198, A:C.251, A:C.253, A:C.258
ZN.15: 6 residues within 4Å:- Chain B: C.57, C.59, C.63, C.68
- Ligands: ZN.16, ZN.17
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.57, B:C.59, B:C.63, B:C.68
ZN.16: 6 residues within 4Å:- Chain B: C.63, C.100, C.106, C.110
- Ligands: ZN.15, ZN.17
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.63, B:C.100, B:C.106, B:C.110
ZN.17: 6 residues within 4Å:- Chain B: C.57, C.70, C.100, C.104
- Ligands: ZN.15, ZN.16
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.57, B:C.70, B:C.100, B:C.104
ZN.18: 4 residues within 4Å:- Chain B: C.198, C.251, C.253, C.258
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.198, B:C.251, B:C.253, B:C.258
- 2 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
SAH.6: 17 residues within 4Å:- Chain A: M.131, G.132, W.133, S.167, Y.168, R.192, F.193, I.194, N.195, H.196, Y.237, F.241, F.249, S.250, C.251, R.252, C.253
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:W.133, A:W.133, A:S.167, A:S.167, A:Y.168, A:Y.168, A:N.195, A:H.196, A:H.196, A:R.252
SAH.19: 16 residues within 4Å:- Chain B: M.131, G.132, W.133, S.167, Y.168, R.192, F.193, I.194, N.195, H.196, Y.237, F.249, S.250, C.251, R.252, C.253
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:W.133, B:W.133, B:S.167, B:S.167, B:Y.168, B:Y.168, B:N.195, B:H.196, B:H.196, B:R.252
- Water bridges: B:R.127
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.7: 5 residues within 4Å:- Chain A: C.59, I.60, D.61, S.65, N.67
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.61, A:S.65
EDO.8: 6 residues within 4Å:- Chain A: N.39, I.47, L.154, H.211, F.216, R.218
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:N.39, A:F.216
- Water bridges: A:N.39, A:R.218, A:R.218
EDO.9: 4 residues within 4Å:- Chain A: M.91, A.92, P.200, T.224
No protein-ligand interaction detected (PLIP)EDO.10: 5 residues within 4Å:- Chain A: G.12, Y.13, E.14, R.15
- Chain B: R.108
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.108
- Water bridges: B:R.108
EDO.11: 4 residues within 4Å:- Chain A: K.34, Y.187
- Chain B: Y.56, A.103
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.187, A:Y.187
- Water bridges: A:K.34, A:K.34
EDO.12: 3 residues within 4Å:- Chain A: Y.56, A.103
- Chain B: K.34
4 PLIP interactions:4 interactions with chain A- Water bridges: A:I.51, A:T.52, A:A.103, A:C.104
EDO.13: 7 residues within 4Å:- Chain A: R.11, Y.13, K.34, Y.35
- Chain B: C.104, S.105, C.106
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:C.106, A:Y.35
- Water bridges: A:K.34
EDO.20: 5 residues within 4Å:- Chain B: D.82, R.113, V.114, N.117, R.120
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.82, B:N.117
EDO.21: 4 residues within 4Å:- Chain B: F.170, D.236, Y.237
- Ligands: JDG.14
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.236
EDO.22: 7 residues within 4Å:- Chain A: Y.13
- Chain B: N.101, H.102, R.108, R.113, Q.116, A.210
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:H.102, B:H.102, B:R.108, B:R.113
- Water bridges: B:R.108, B:Q.116
EDO.23: 3 residues within 4Å:- Chain B: D.80, K.81, R.111
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:K.81, B:R.111, B:R.111
- Water bridges: B:D.80
EDO.24: 5 residues within 4Å:- Chain B: C.59, I.60, D.61, S.65, N.67
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:I.60, B:D.61, B:S.65, B:S.65, B:N.67
- Water bridges: B:V.58
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Milite, C. et al., Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure. J. Med. Chem. (2019)
- Release Date
- 2019-02-27
- Peptides
- Histone-lysine N-methyltransferase EHMT1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x JDG: 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine(Non-covalent)
- 8 x ZN: ZINC ION(Non-covalent)
- 2 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Milite, C. et al., Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure. J. Med. Chem. (2019)
- Release Date
- 2019-02-27
- Peptides
- Histone-lysine N-methyltransferase EHMT1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B